| NCT03553563 |
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer |
https://ClinicalTrials.gov/show/NCT03553563 |
Recruiting |
AstraZeneca |
2023-01-04 |
| NCT03367195 |
Efficacy and Safety of DLBS2411 in the Management of GERD |
https://ClinicalTrials.gov/show/NCT03367195 |
Recruiting |
Dexa Medica Group |
2020-10-31 |
| NCT03341585 |
Influence of Expiration Lente Prolongée on Gastro-oesophageal Reflux |
https://ClinicalTrials.gov/show/NCT03341585 |
Recruiting |
Vrije Universiteit Brussel |
2021-01-01 |
| NCT03322553 |
Endoscopic Full Thickness Plication (GERD-X) for the Treatment of PPI Dependent GERD: |
https://ClinicalTrials.gov/show/NCT03322553 |
Completed |
Asian Institute of Gastroenterology, India |
2019-08-30 |
| NCT03299985 |
Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03299985 |
Completed |
Cardenal Herrera University |
2018-03-15 |
| NCT03284177 |
A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients |
https://ClinicalTrials.gov/show/NCT03284177 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2018-12-04 |
| NCT03278327 |
Impact of an Endoscopic Treatment of the Line Z on the Gastronomic Recurrence and the Gastro- Esophageal Reflux Disease in the Care of the Adenocarcinoma of Barrett’s Oesophagus |
https://ClinicalTrials.gov/show/NCT03278327 |
Recruiting |
Institut Paoli-Calmettes |
2019-06-30 |
| NCT03270722 |
Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing |
https://ClinicalTrials.gov/show/NCT03270722 |
Recruiting |
Stanford University |
2020-05-31 |
| NCT03259191 |
Anti-reflux Mucosectomy (ARMS) is a Useful Therapy for Refractory Gastroesophageal Reflux Disease (RGERD) |
https://ClinicalTrials.gov/show/NCT03259191 |
Recruiting |
Zhongda Hospital |
2017-11-20 |
| NCT03258528 |
Effect of Right Lateral Position on Ventilated Preterm Neonates |
https://ClinicalTrials.gov/show/NCT03258528 |
Completed |
Ain Shams University |
2016-12-14 |
| NCT03202537 |
Effectiveness of Physiologic Testing in PPI Non-Responders |
https://ClinicalTrials.gov/show/NCT03202537 |
Enrolling by invitation |
Northwestern University |
2021-10-01 |
| NCT03184324 |
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study) |
https://ClinicalTrials.gov/show/NCT03184324 |
Completed |
Daewoong Pharmaceutical Co. LTD. |
2018-04-18 |
| NCT03130543 |
A Trial of Thickened Feeds to Treat Gastroesophageal Reflux in Children Admitted After Choking Spell |
https://ClinicalTrials.gov/show/NCT03130543 |
Recruiting |
Boston Children’s Hospital |
2022-03-06 |
| NCT03128736 |
Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B |
https://ClinicalTrials.gov/show/NCT03128736 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2016-02-28 |
| NCT03116841 |
Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation |
https://ClinicalTrials.gov/show/NCT03116841 |
Completed |
Takeda |
2017-12-20 |
| NCT03097887 |
Omega Loop Gastric Bypass With And Without Anti-Reflux Sutures |
https://ClinicalTrials.gov/show/NCT03097887 |
Recruiting |
Medical University of Vienna |
2020-07-01 |
| NCT03086070 |
Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis |
https://ClinicalTrials.gov/show/NCT03086070 |
Completed |
Children’s Hospital Srebrnjak |
2010-04-30 |
| NCT03069963 |
PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT03069963 |
Completed |
Sanofi |
2017-04-23 |
| NCT03065816 |
Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT03065816 |
Completed |
Sanofi |
2017-05-02 |
| NCT03041649 |
Mic-Key Versus Mini One Family Preference Comparison |
https://ClinicalTrials.gov/show/NCT03041649 |
Active, not recruiting |
Children’s Mercy Hospital Kansas City |
2024-11-30 |
| NCT03037606 |
Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets |
https://ClinicalTrials.gov/show/NCT03037606 |
Completed |
Neutec Ar-Ge San ve Tic A.Åž |
2018-12-01 |
| NCT03031288 |
Effects of Vented Base Feeding Bottle in Preterm Infants With GERD Symptoms. |
https://ClinicalTrials.gov/show/NCT03031288 |
Completed |
University of Turin, Italy |
2018-12-01 |
| NCT03015610 |
Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma |
https://ClinicalTrials.gov/show/NCT03015610 |
Recruiting |
Duke University |
2020-08-31 |
| NCT02987673 |
MGB/OAGB and LSG Effects on Lower Esophageal Sphincter (LES) Function |
https://ClinicalTrials.gov/show/NCT02987673 |
Recruiting |
Federico II University |
2019-12-31 |
| NCT02972047 |
Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux |
https://ClinicalTrials.gov/show/NCT02972047 |
Recruiting |
Mayo Clinic |
2020-09-30 |
| NCT02958046 |
The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity |
https://ClinicalTrials.gov/show/NCT02958046 |
Completed |
Neutec Ar-Ge San ve Tic A.Åž |
2015-05-31 |
| NCT02930824 |
Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing |
https://ClinicalTrials.gov/show/NCT02930824 |
Completed |
University of Florida |
2019-07-17 |
| NCT02907632 |
Methoclopramide for Gastroesophageal Reflux in Premature Infants |
https://ClinicalTrials.gov/show/NCT02907632 |
Recruiting |
Kangaroo Foundation |
2019-01-31 |
| NCT02893709 |
Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES) |
https://ClinicalTrials.gov/show/NCT02893709 |
Completed |
Changi General Hospital |
2016-07-31 |
| NCT02892357 |
Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease |
https://ClinicalTrials.gov/show/NCT02892357 |
Recruiting |
Xiyuan Hospital of China Academy of Chinese Medical Sciences |
2019-09-30 |
| NCT02890979 |
Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT02890979 |
Active, not recruiting |
OHSU Knight Cancer Institute |
2020-12-31 |
| NCT02873689 |
Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients |
https://ClinicalTrials.gov/show/NCT02873689 |
Completed |
Takeda |
2018-03-14 |
| NCT02860624 |
Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients |
https://ClinicalTrials.gov/show/NCT02860624 |
Completed |
Livzon Pharmaceutical Group Inc. |
2013-04-30 |
| NCT02794844 |
Implementation of PPI Medication PGX Testing |
https://ClinicalTrials.gov/show/NCT02794844 |
Completed |
Nemours Children’s Clinic |
2017-01-23 |
| NCT02788591 |
Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection |
https://ClinicalTrials.gov/show/NCT02788591 |
Recruiting |
LCMC Health |
2020-12-31 |
| NCT02786810 |
Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy |
https://ClinicalTrials.gov/show/NCT02786810 |
Completed |
University of Tennessee |
2016-11-30 |
| NCT02783378 |
48 Hours Esophagal pH-monitoring With and Without Gaviscon |
https://ClinicalTrials.gov/show/NCT02783378 |
Completed |
Universitair Ziekenhuis Brussel |
2017-08-01 |
| NCT02776982 |
Influence of Central Obesity on the Esophageal Epithelial Barrier |
https://ClinicalTrials.gov/show/NCT02776982 |
Active, not recruiting |
Mayo Clinic |
2020-06-30 |
| NCT02755753 |
A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT02755753 |
Completed |
Severance Hospital |
2016-01-31 |
| NCT02743949 |
Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI) |
https://ClinicalTrials.gov/show/NCT02743949 |
Completed |
Takeda |
2018-10-05 |
| NCT02710955 |
SWAN: Study on the Tolerance and Efficacy of a New Anti-regurgitation Formula (PC-2016-01) |
https://ClinicalTrials.gov/show/NCT02710955 |
Completed |
United Pharmaceuticals |
2017-01-21 |
| NCT02706938 |
Impact of Head of Bed Elevation in Symptoms of Patients With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT02706938 |
Completed |
Universidad Nacional de Colombia |
2017-11-15 |
| NCT02689999 |
The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity |
https://ClinicalTrials.gov/show/NCT02689999 |
Completed |
Neutec Ar-Ge San ve Tic A.Åž |
2017-05-31 |
| NCT02685436 |
Role of Pepsin Assay in Wheezy Infants |
https://ClinicalTrials.gov/show/NCT02685436 |
Completed |
Mansoura University Children Hospital |
2015-05-31 |
| NCT02685150 |
Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease |
https://ClinicalTrials.gov/show/NCT02685150 |
Completed |
Chinese PLA General Hospital |
2018-06-30 |
| NCT02670642 |
Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD |
https://ClinicalTrials.gov/show/NCT02670642 |
Completed |
AstraZeneca |
2002-11-30 |
| NCT02637557 |
A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT02637557 |
Completed |
Ironwood Pharmaceuticals, Inc. |
2017-04-26 |
| NCT02623062 |
Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study |
https://ClinicalTrials.gov/show/NCT02623062 |
Completed |
Reckitt Benckiser Healthcare (UK) Limited |
2016-03-31 |
| NCT02620241 |
Influence of Intrapulmonary Percussive Ventilation (IPV) on Gastro-oesophageal Reflux (GOR). |
https://ClinicalTrials.gov/show/NCT02620241 |
Completed |
Vrije Universiteit Brussel |
2017-10-31 |
| NCT02592902 |
Recurrent Respiratory Papillomatosis and Extraesophageal Reflux |
https://ClinicalTrials.gov/show/NCT02592902 |
Completed |
University Hospital Ostrava |
2018-08-31 |
| NCT02558049 |
Should I Continue Taking My Acid Reflux Medication? Development and Pilot Testing of a Patient Decision Aid |
https://ClinicalTrials.gov/show/NCT02558049 |
Completed |
University of Ottawa |
2016-12-31 |
| NCT02556021 |
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease |
https://ClinicalTrials.gov/show/NCT02556021 |
Completed |
CJ HealthCare Corporation |
2016-11-01 |
| NCT02530216 |
Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes |
https://ClinicalTrials.gov/show/NCT02530216 |
Completed |
Cedars-Sinai Medical Center |
2018-02-07 |
| NCT02505945 |
The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease |
https://ClinicalTrials.gov/show/NCT02505945 |
Completed |
Torax Medical Incorporated |
2017-10-31 |
| NCT02486263 |
Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial |
https://ClinicalTrials.gov/show/NCT02486263 |
Active, not recruiting |
Nationwide Children’s Hospital |
2020-03-31 |
| NCT02457429 |
A Validation Study of the Dx-pH Probe in Children for the Detection of Extra-oesophageal Reflux |
https://ClinicalTrials.gov/show/NCT02457429 |
Completed |
Manchester University NHS Foundation Trust |
2017-04-28 |
| NCT02445014 |
Pilot Study to Image the Esophagus Using a SECM Tethered Endoscopic Capsule |
https://ClinicalTrials.gov/show/NCT02445014 |
Completed |
Massachusetts General Hospital |
2016-01-31 |
| NCT02436057 |
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform |
https://ClinicalTrials.gov/show/NCT02436057 |
Completed |
Cedars-Sinai Medical Center |
2015-12-31 |
| NCT02429830 |
A Study of Reflux Management With the LINX® System for Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy |
https://ClinicalTrials.gov/show/NCT02429830 |
Active, not recruiting |
Torax Medical Incorporated |
2021-12-31 |
| NCT02425423 |
Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula |
https://ClinicalTrials.gov/show/NCT02425423 |
Completed |
United Pharmaceuticals |
2014-03-31 |
| NCT02401035 |
PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric Subjects |
https://ClinicalTrials.gov/show/NCT02401035 |
Recruiting |
Pfizer |
2022-04-11 |
| NCT02384551 |
Dietary Carbohydrate and GERD in Veterans |
https://ClinicalTrials.gov/show/NCT02384551 |
Recruiting |
VA Office of Research and Development |
2020-09-30 |
| NCT02359604 |
The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study |
https://ClinicalTrials.gov/show/NCT02359604 |
Completed |
Medical University of Graz |
2017-02-07 |
| NCT02351960 |
Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT02351960 |
Completed |
Takeda |
2016-06-22 |
| NCT02336100 |
Diagnostic Value of Flexible Spectral Imaging Color Enhancement (FICE) Plus Probe-based Confocal Laser Endomicroscopy (pCLE) for Minimal Change Esophageal Reflux Disease (MERD) Diagnosis |
https://ClinicalTrials.gov/show/NCT02336100 |
Completed |
King Chulalongkorn Memorial Hospital |
2012-02-29 |
| NCT02318862 |
Assessment of Esophageal Epithelium Integrity With Mucosal Impedance |
https://ClinicalTrials.gov/show/NCT02318862 |
Completed |
Vanderbilt University Medical Center |
2016-12-31 |
| NCT02288988 |
Minimally Invasive Collis-Nissen for the Treatment of Short Esophagus |
https://ClinicalTrials.gov/show/NCT02288988 |
Completed |
University of Bologna |
2013-12-31 |
| NCT02226484 |
Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? |
https://ClinicalTrials.gov/show/NCT02226484 |
Completed |
University of North Carolina, Chapel Hill |
2016-05-31 |
| NCT02200055 |
Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need |
https://ClinicalTrials.gov/show/NCT02200055 |
Completed |
United States Naval Medical Center, Portsmouth |
2015-07-31 |
| NCT02186652 |
PK Study With Pantoprazole in Obese Children and Adolescents |
https://ClinicalTrials.gov/show/NCT02186652 |
Completed |
Duke University |
2015-09-13 |
| NCT02154659 |
The Difference of Reflux Pattern Between the Patients Who Have Postprandial Reflux Symptoms |
https://ClinicalTrials.gov/show/NCT02154659 |
Completed |
Yonsei University |
2015-12-07 |
| NCT02153398 |
A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases |
https://ClinicalTrials.gov/show/NCT02153398 |
Completed |
AstraZeneca |
2016-04-30 |
| NCT02141711 |
TAK-438 - Safety, Blood Levels & Effects of Repeated Doses |
https://ClinicalTrials.gov/show/NCT02141711 |
Completed |
Takeda |
2009-02-28 |
| NCT02135107 |
A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients |
https://ClinicalTrials.gov/show/NCT02135107 |
Completed |
Eisai Inc. |
2016-05-31 |
| NCT02128867 |
Safety Study of Airway Clearance Techniques in Infants. |
https://ClinicalTrials.gov/show/NCT02128867 |
Completed |
Vrije Universiteit Brussel |
2015-01-31 |
| NCT02124863 |
Influence of IPV on GOR in Infants From 0 to 12 Months. |
https://ClinicalTrials.gov/show/NCT02124863 |
Completed |
Vrije Universiteit Brussel |
2015-01-31 |
| NCT02114216 |
Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT02114216 |
Completed |
Seoul National University Bundang Hospital |
2014-08-31 |
| NCT02100189 |
Esophageal Cytology With FISH in Detecting Esophageal Cancer |
https://ClinicalTrials.gov/show/NCT02100189 |
Completed |
OHSU Knight Cancer Institute |
2015-12-31 |
| NCT02096458 |
Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets |
https://ClinicalTrials.gov/show/NCT02096458 |
Completed |
Takeda |
2014-02-28 |
| NCT02081404 |
Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study |
https://ClinicalTrials.gov/show/NCT02081404 |
Recruiting |
Midwest Biomedical Research Foundation |
2020-03-31 |
| NCT02072447 |
Absolute Bioavailability of YH4808 With Accelerator Mass Spectrometry(AMS)-Based Microdose Study |
https://ClinicalTrials.gov/show/NCT02072447 |
Completed |
Seoul National University Hospital |
2014-04-30 |
| NCT02060500 |
Cardiaplication: A Novel Antireflux Operation |
https://ClinicalTrials.gov/show/NCT02060500 |
Completed |
Emory University |
2015-02-28 |
| NCT01307982 |
Comparative Anti-Reflux Procedures in Neurologically Impaired Children |
https://ClinicalTrials.gov/show/NCT01307982 |
Completed |
University of Utah |
2013-09-30 |
| NCT01288612 |
Comparative Effectiveness of Endoscopic Assessment of Gastroesophageal Reflux and Barretts Esophagus |
https://ClinicalTrials.gov/show/NCT01288612 |
Completed |
Mayo Clinic |
2013-10-31 |
| NCT01269788 |
Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial |
https://ClinicalTrials.gov/show/NCT01269788 |
Completed |
Tehran University of Medical Sciences |
2011-08-31 |
| NCT02030925 |
Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors |
https://ClinicalTrials.gov/show/NCT02030925 |
Completed |
Ironwood Pharmaceuticals, Inc. |
2014-12-31 |
| NCT04454112 |
Pre and Post-gastrostomy Evaluation of GER in Children Using 24-hour pH Monitoring |
https://ClinicalTrials.gov/show/NCT04454112 |
Completed |
Ondokuz Mayıs University |
2018-12-12 |
| NCT03346174 |
Influence of Airway Clearance Techniques on GOR in Infants |
https://ClinicalTrials.gov/show/NCT03346174 |
Recruiting |
Vrije Universiteit Brussel |
2021-01-01 |
| NCT01946971 |
Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER) |
https://ClinicalTrials.gov/show/NCT01946971 |
Completed |
Seoul National University Hospital |
2014-07-31 |
| NCT01915173 |
Response to Supplement and Placebo in GERD |
https://ClinicalTrials.gov/show/NCT01915173 |
Completed |
Beth Israel Deaconess Medical Center |
2014-04-30 |
| NCT01888549 |
Efficacy of Proton Pump Inhibitor for Chronic Cough Caused by Gastroesophageal Reflux; Double-blind, Placebo-controlled, Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT01888549 |
Completed |
Yonsei University |
2016-02-29 |
| NCT01882088 |
Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD |
https://ClinicalTrials.gov/show/NCT01882088 |
Completed |
Russian Academy of Medical Sciences |
2016-09-30 |
| NCT01880892 |
Laryngopharyngeal Reflux Before and After Cricopharyngeal Myotomy |
https://ClinicalTrials.gov/show/NCT01880892 |
Recruiting |
Mayo Clinic |
2022-04-30 |
| NCT01878526 |
Gastroesophageal Reflux Treatment in Scleroderma |
https://ClinicalTrials.gov/show/NCT01878526 |
Completed |
Khon Kaen University |
2015-08-31 |
| NCT01872897 |
Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients |
https://ClinicalTrials.gov/show/NCT01872897 |
Completed |
Reckitt Benckiser Healthcare (UK) Limited |
2013-12-31 |
| NCT01869491 |
Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study |
https://ClinicalTrials.gov/show/NCT01869491 |
Completed |
Reckitt Benckiser Healthcare (UK) Limited |
2014-05-31 |
| NCT01857713 |
Treatment of Extraesophageal Reflux With the Reza Band UES Assist Device |
https://ClinicalTrials.gov/show/NCT01857713 |
Completed |
Somna Therapeutics, L.L.C. |
2013-09-30 |
| NCT01854970 |
Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux |
https://ClinicalTrials.gov/show/NCT01854970 |
Completed |
University Hospital, Bordeaux |
2015-07-31 |
| NCT01844440 |
Diagnostic of Transient Lower Esophageal Sphincter Relaxation With Combined Impedance and High Resolution Manometry in Patients With GERD |
https://ClinicalTrials.gov/show/NCT01844440 |
Completed |
University Hospital, Bordeaux |
2014-01-31 |
| NCT01819454 |
The Diagnostics of Extraesophageal Reflux With the Restech System |
https://ClinicalTrials.gov/show/NCT01819454 |
Completed |
University Hospital Ostrava |
2015-09-30 |
| NCT01818570 |
A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus |
https://ClinicalTrials.gov/show/NCT01818570 |
Completed |
Aalborg University Hospital |
2014-01-31 |
| NCT01806220 |
Laryngeal and Esophageal EGF-r Expression in Patients With Reflux Laryngitis |
https://ClinicalTrials.gov/show/NCT01806220 |
Completed |
Faculdade de Ciências Médicas da Santa Casa de São Paulo |
2007-12-31 |
| NCT01798212 |
Prospective Trial on the Clinical Feasibility of a New Full Thickness Endoscopic Plication Device for Patients With GERD. |
https://ClinicalTrials.gov/show/NCT01798212 |
Completed |
Krankenhaus Barmherzige Schwestern Linz |
2016-12-31 |
| NCT01778101 |
Lansoprazole in Preterm Infants With Reflux |
https://ClinicalTrials.gov/show/NCT01778101 |
Completed |
Seoul National University Hospital |
2013-05-31 |
| NCT01753128 |
Efficacy of Imipramine for Treatment of Patients With Esophageal Hypersensitivity/ Functional Heartburn |
https://ClinicalTrials.gov/show/NCT01753128 |
Completed |
Mahidol University |
2013-09-30 |
| NCT01750437 |
Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD) |
https://ClinicalTrials.gov/show/NCT01750437 |
Completed |
Yuhan Corporation |
2013-10-31 |
| NCT01733810 |
The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT01733810 |
Completed |
Dallas VA Medical Center |
2015-07-31 |
| NCT01710995 |
A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions |
https://ClinicalTrials.gov/show/NCT01710995 |
Completed |
Norgine |
2010-11-30 |
| NCT01696734 |
Domperidone in Treating Patients With Gastrointestinal Disorders |
https://ClinicalTrials.gov/show/NCT01696734 |
Recruiting |
M.D. Anderson Cancer Center |
2021-10-31 |
| NCT01682265 |
Stretta In Reflux Uncontrolled by IPP |
https://ClinicalTrials.gov/show/NCT01682265 |
Completed |
Nantes University Hospital |
2018-11-27 |
| NCT01669811 |
Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus) |
https://ClinicalTrials.gov/show/NCT01669811 |
Completed |
AstraZeneca |
2014-05-31 |
| NCT01669330 |
Laparoscopic Nissen Versus Anterior Partial Fundoplication |
https://ClinicalTrials.gov/show/NCT01669330 |
Completed |
Region Skane |
2013-12-31 |
| NCT01657578 |
Optimal Dosing of Omeprazole in Neonates |
https://ClinicalTrials.gov/show/NCT01657578 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2010-12-31 |
| NCT01642615 |
Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents |
https://ClinicalTrials.gov/show/NCT01642615 |
Completed |
Takeda |
2014-11-30 |
| NCT01642602 |
Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents |
https://ClinicalTrials.gov/show/NCT01642602 |
Completed |
Takeda |
2014-01-31 |
| NCT01578642 |
Feasibility Study for Evaluating the Effect of Electrical Stimulation on Lower Esophageal Sphincter Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01578642 |
Completed |
EndoStim Inc. |
2013-05-31 |
| NCT01538849 |
Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT01538849 |
Completed |
Yuhan Corporation |
2013-11-30 |
| NCT01503476 |
Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance |
https://ClinicalTrials.gov/show/NCT01503476 |
Completed |
Medtronic - MITG |
2016-03-31 |
| NCT01493089 |
Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01493089 |
Completed |
Norgine |
2011-10-31 |
| NCT01474369 |
Efficacy of TAK-438 Compared to Placebo in the Treatment of Non-Erosive Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01474369 |
Completed |
Takeda |
2013-02-28 |
| NCT01472939 |
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT01472939 |
Completed |
Shire |
2013-05-31 |
| NCT01450748 |
Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux |
https://ClinicalTrials.gov/show/NCT01450748 |
Completed |
TTY Biopharm |
2015-03-31 |
| NCT01400945 |
Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01400945 |
Completed |
Ahn-Gook Pharmaceuticals Co.,Ltd |
2011-08-31 |
| NCT01397084 |
To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole |
https://ClinicalTrials.gov/show/NCT01397084 |
Completed |
AstraZeneca |
2012-01-31 |
| NCT01390714 |
Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects |
https://ClinicalTrials.gov/show/NCT01390714 |
Completed |
Eisai Inc. |
2011-10-31 |
| NCT01381991 |
The Efficacy of i-Scan for Detecting Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT01381991 |
Completed |
Konkuk University Hospital |
2010-11-30 |
| NCT01364610 |
An Assessment of pH Testing Methods |
https://ClinicalTrials.gov/show/NCT01364610 |
Completed |
University of Calgary |
2008-12-31 |
| NCT01349413 |
BRAVO Study for Functional Dyspepsia |
https://ClinicalTrials.gov/show/NCT01349413 |
Completed |
Chinese University of Hong Kong |
2017-12-30 |
| NCT01338077 |
Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01338077 |
Completed |
Chang Gung Memorial Hospital |
2012-01-31 |
| NCT01324986 |
A Study on the Effectiveness of Laparoscopic Fundoplication on Extraesophageal Manifestations of Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT01324986 |
Completed |
General Public Hospital Zell am See |
NA |
| NCT01324791 |
Laparoscopic Antireflux Surgery Versus Endoscopic Full-thickness Gastroplication for Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT01324791 |
Completed |
General Public Hospital Zell am See |
NA |
| NCT01321294 |
Laparoscopic Nissen Versus Toupet Fundoplication: Objective and Subjective Results of a Prospective Randomized Trial |
https://ClinicalTrials.gov/show/NCT01321294 |
Completed |
General Public Hospital Zell am See |
NA |
| NCT04436159 |
Partial Versus Total Fundoplication in the Surgical Repair of Para-esophageal Hernia. |
https://ClinicalTrials.gov/show/NCT04436159 |
Recruiting |
Karolinska University Hospital |
2020-09-30 |
| NCT04410211 |
Comparison Between Two Types of Sedation for Elective Upper Endoscopy Procedures |
https://ClinicalTrials.gov/show/NCT04410211 |
Completed |
University of Malaya |
2019-11-30 |
| NCT04355455 |
Effects of Serotonin Agonist Citalopram on Multimodal Esophageal Stimulation in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04355455 |
Completed |
Universitaire Ziekenhuizen Leuven |
2011-12-31 |
| NCT04352686 |
Effects of Serotonin Agonist Buspirone on Multimodal Esophageal Stimulation in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04352686 |
Completed |
Universitaire Ziekenhuizen Leuven |
2012-09-30 |
| NCT04335734 |
Influence of Wrap Fixation Technique on the Results of Fundoplication |
https://ClinicalTrials.gov/show/NCT04335734 |
Completed |
Odessa National Medical University |
2014-10-01 |
| NCT04325620 |
Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease |
https://ClinicalTrials.gov/show/NCT04325620 |
Recruiting |
Hanmi Pharmaceutical Company Limited |
2020-07-16 |
| NCT04292470 |
Physiology of GERD and Treatment Response |
https://ClinicalTrials.gov/show/NCT04292470 |
Recruiting |
University of California, Davis |
2021-11-30 |
| NCT04287972 |
A Study to Reduce the Reflux After a Sleeve Gastrectomy in Obese Patients |
https://ClinicalTrials.gov/show/NCT04287972 |
Recruiting |
Ente Ospedaliero Cantonale, Bellinzona |
2022-10-31 |
| NCT04282954 |
Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT04282954 |
Recruiting |
Jeil Pharmaceutical Co., Ltd. |
2020-11-30 |
| NCT04255693 |
Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence |
https://ClinicalTrials.gov/show/NCT04255693 |
Recruiting |
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology |
2023-12-31 |
| NCT04253444 |
The Effect of Autonomic Modulation on Symptoms in Patients With Reflux Hypersensitivity |
https://ClinicalTrials.gov/show/NCT04253444 |
Recruiting |
Queen Mary University of London |
2021-02-01 |
| NCT04202692 |
Effect of a Combination Oral Formulation of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate in Patients With Gastro-Esophageal Reflux Disease Not Fully Satisfied With Their Treatment |
https://ClinicalTrials.gov/show/NCT04202692 |
Recruiting |
SOFAR S.p.A. |
2020-12-31 |
| NCT04202276 |
The Study of Nutrition of Children and Adolescents With GERD |
https://ClinicalTrials.gov/show/NCT04202276 |
Enrolling by invitation |
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology |
2019-06-30 |
| NCT04194723 |
Antireflux Mucosectomy (ARMS) for Treatment of Gastroesophageal Reflux |
https://ClinicalTrials.gov/show/NCT04194723 |
Recruiting |
Chinese University of Hong Kong |
2021-12-31 |
| NCT04152798 |
Approach to Hiatal Hernia Repair Based on Collagen Study |
https://ClinicalTrials.gov/show/NCT04152798 |
Completed |
Odessa National Medical University |
2019-09-20 |
| NCT04130659 |
Study to Evaluate the Performance and Safety of the Marial in Association With PPI Versus PPI Alone |
https://ClinicalTrials.gov/show/NCT04130659 |
Recruiting |
Nekkar Lab Srl |
2019-11-30 |
| NCT04118647 |
Effective Mechanisms of Wu-Chu-Yu Tang on Gastroesophageal Disorder |
https://ClinicalTrials.gov/show/NCT04118647 |
Recruiting |
China Medical University Hospital |
2021-09-30 |
| NCT04080726 |
Efficacy and Safety of HIP1601 Capsule |
https://ClinicalTrials.gov/show/NCT04080726 |
Recruiting |
Hanmi Pharmaceutical Company Limited |
2019-11-30 |
| NCT04065516 |
ARAT for Reflux Disease After Peroral Endoscopic Myotomy in Patients With Achalasia |
https://ClinicalTrials.gov/show/NCT04065516 |
Enrolling by invitation |
Coordinación de Investigación en Salud, Mexico |
2019-11-01 |
| NCT04036942 |
Antireflux Ablation Therapy (ARAT) Vs Antireflux Mucosectomy (ARMS) In The Management Of Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT04036942 |
Recruiting |
Coordinación de Investigación en Salud, Mexico |
2019-11-01 |
| NCT04028466 |
Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features |
https://ClinicalTrials.gov/show/NCT04028466 |
Recruiting |
St. Luke’s Medical Center, Philippines |
2020-11-30 |
| NCT04001400 |
Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux. |
https://ClinicalTrials.gov/show/NCT04001400 |
Completed |
Seoul National University Hospital |
2014-05-21 |
| NCT03999502 |
Endomina Suturing Device as a Treatment of GERD. |
https://ClinicalTrials.gov/show/NCT03999502 |
Recruiting |
Erasme University Hospital |
2020-05-12 |
| NCT03998969 |
Efficacy of DA-5204 on Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03998969 |
Completed |
Seoul National University Hospital |
2018-12-11 |
| NCT03928470 |
Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg |
https://ClinicalTrials.gov/show/NCT03928470 |
Completed |
Chong Kun Dang Pharmaceutical |
2019-12-20 |
| NCT03904758 |
Extraesophageal Reflux - Feasibility of Measurement of Pepsin in Saliva as a Diagnostic Option |
https://ClinicalTrials.gov/show/NCT03904758 |
Recruiting |
University Hospital Ostrava |
2021-11-30 |
| NCT03904472 |
Cognitive Behavioral Therapy for Insomnia (CBTI) in GERD Patients With Insomnia |
https://ClinicalTrials.gov/show/NCT03904472 |
Recruiting |
University of Michigan |
2021-04-30 |
| NCT03883074 |
Effect of a Combination of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate on Subjects With GastroEsophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03883074 |
Recruiting |
SOFAR S.p.A. |
2020-10-31 |
| NCT03881722 |
Effect of Magnesium Alginate in Infants With Gastroesophageal Reflux. |
https://ClinicalTrials.gov/show/NCT03881722 |
Completed |
Policlinico Hospital |
2018-12-31 |
| NCT03835442 |
A Placebo Controlled Trial With Baclofen for the Treatment of GERD Patients With Incomplete PPI Response |
https://ClinicalTrials.gov/show/NCT03835442 |
Completed |
Universitaire Ziekenhuizen Leuven |
2016-12-31 |
| NCT03811080 |
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease |
https://ClinicalTrials.gov/show/NCT03811080 |
Recruiting |
Daewoong Pharmaceutical Co. LTD. |
2020-02-29 |
| NCT03793556 |
Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor |
https://ClinicalTrials.gov/show/NCT03793556 |
Completed |
SOFAR S.p.A. |
2018-09-20 |
| NCT03788109 |
Relationship Between Gastric Accommodation, TLESRs and Reflux in HV and in GERD With or Without Overlapping Dyspepsia |
https://ClinicalTrials.gov/show/NCT03788109 |
Completed |
Universitaire Ziekenhuizen Leuven |
2018-06-15 |
| NCT03777787 |
Bitter Tastants and Reflux |
https://ClinicalTrials.gov/show/NCT03777787 |
Completed |
Universitaire Ziekenhuizen Leuven |
2019-05-10 |
| NCT03776669 |
Laparoscopic Sleeve Gastrectomy With or Without Hiatal Hernia Repair in Morbidly Obese Patients |
https://ClinicalTrials.gov/show/NCT03776669 |
Recruiting |
National Taiwan University Hospital |
2020-11-01 |
| NCT03746691 |
Effect of Citalopram on Reflux Episodes in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03746691 |
Completed |
Universitaire Ziekenhuizen Leuven |
2017-07-31 |
| NCT03736369 |
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) |
https://ClinicalTrials.gov/show/NCT03736369 |
Completed |
Daewoong Pharmaceutical Co. LTD. |
2019-08-07 |
| NCT03692455 |
Clinico-functional Evaluation of GERD: Comparative Study of Vertical Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass |
https://ClinicalTrials.gov/show/NCT03692455 |
Completed |
Clinica Gastrobese |
2018-08-13 |
| NCT03676374 |
Prucalopride Treatment for Refractory Gastro-esophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03676374 |
Recruiting |
Universitaire Ziekenhuizen Leuven |
2021-04-30 |
| NCT03659487 |
Comparison of Total and Partial Fundoplication During Surgery of Patients With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03659487 |
Completed |
Karolinska Institutet |
2011-04-30 |
| NCT03634449 |
Risks of Gastroesophageal Reflux in the Endotracheal Intubation or the I-gel |
https://ClinicalTrials.gov/show/NCT03634449 |
Recruiting |
National Taiwan University Hospital |
2019-10-13 |
| NCT03619811 |
Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03619811 |
Recruiting |
University of California, San Diego |
2020-07-31 |
| NCT03591653 |
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks |
https://ClinicalTrials.gov/show/NCT03591653 |
Completed |
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. |
2019-10-30 |
| NCT03561883 |
Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors |
https://ClinicalTrials.gov/show/NCT03561883 |
Recruiting |
Ironwood Pharmaceuticals, Inc. |
2021-06-30 |
| NCT03561233 |
Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03561233 |
Completed |
Khon Kaen University |
2018-05-31 |
| NCT03548298 |
Antireflux Ablation Therapy (ARAT) for Gastroesophageal Reflux Treatment |
https://ClinicalTrials.gov/show/NCT03548298 |
Completed |
Coordinación de Investigación en Salud, Mexico |
2019-07-01 |
| NCT03516188 |
Efficacy of Gaviscon-Advance® in Suppressing Post-supper Acid-pocket and Night-time Acid-reflux in Obese Participants |
https://ClinicalTrials.gov/show/NCT03516188 |
Completed |
Universiti Sains Malaysia |
2017-06-30 |
| NCT03497494 |
the Related Factors of Bariatric Surgery on Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03497494 |
Active, not recruiting |
First Affiliated Hospital of Jinan University |
2019-12-30 |
| NCT03476265 |
Lower Esophageal Sphincter (LES) Stimulation in Patients With Ineffective Esophageal Motility |
https://ClinicalTrials.gov/show/NCT03476265 |
Completed |
Austrian Society Of Surgical Oncology |
2018-01-15 |
| NCT03467438 |
Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03467438 |
Recruiting |
IRCCS Policlinico S. Matteo |
2020-04-01 |
| NCT03444883 |
Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD |
https://ClinicalTrials.gov/show/NCT03444883 |
Completed |
Il-Yang Pharm. Co., Ltd. |
2020-02-25 |
| NCT03436914 |
Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03436914 |
Completed |
Yonsei University |
2019-10-18 |
| NCT03425097 |
Fexofenadine Use in Gastroesophageal Reflux Symptoms |
https://ClinicalTrials.gov/show/NCT03425097 |
Recruiting |
Stanford University |
2020-03-31 |
| NCT03417817 |
Oesophageal Acid Exposure in Healthy Subjects Over 96 Hours |
https://ClinicalTrials.gov/show/NCT03417817 |
Completed |
Guy’s and St Thomas’ NHS Foundation Trust |
2019-06-30 |
| NCT01265550 |
A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors |
https://ClinicalTrials.gov/show/NCT01265550 |
Completed |
VA Office of Research and Development |
2016-12-30 |
| NCT01260935 |
Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures |
https://ClinicalTrials.gov/show/NCT01260935 |
Completed |
Swedish Medical Center |
2010-11-30 |
| NCT01212614 |
Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients |
https://ClinicalTrials.gov/show/NCT01212614 |
Completed |
University of Zurich |
2012-09-30 |
| NCT01161602 |
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT01161602 |
Completed |
Edusa Pharmaceuticals, Inc. |
NA |
| NCT01154634 |
Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT01154634 |
Completed |
AstraZeneca |
2010-09-30 |
| NCT01149395 |
Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn |
https://ClinicalTrials.gov/show/NCT01149395 |
Completed |
University of North Carolina, Chapel Hill |
2012-04-30 |
| NCT01136980 |
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study |
https://ClinicalTrials.gov/show/NCT01136980 |
Completed |
EndoGastric Solutions |
2015-04-30 |
| NCT01136317 |
Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects |
https://ClinicalTrials.gov/show/NCT01136317 |
Completed |
Nantes University Hospital |
2010-07-31 |
| NCT01135368 |
Safety and Efficacy of Lansoprazole in Patients With Reflux Disease |
https://ClinicalTrials.gov/show/NCT01135368 |
Completed |
Takeda |
2008-09-30 |
| NCT01132638 |
Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01132638 |
Completed |
Takeda |
2012-06-30 |
| NCT01126034 |
Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention |
https://ClinicalTrials.gov/show/NCT01126034 |
Completed |
University of Pennsylvania |
2008-04-30 |
| NCT01119768 |
Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients |
https://ClinicalTrials.gov/show/NCT01119768 |
Completed |
AstraZeneca |
2011-06-30 |
| NCT01118585 |
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT01118585 |
Completed |
EndoGastric Solutions |
2015-06-30 |
| NCT01110811 |
Transoral Incisionless Fundoplication (TIF) Versus Sham for Treatment of Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT01110811 |
Completed |
EndoGastric Solutions |
2015-09-30 |
| NCT01101646 |
A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT01101646 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2008-09-30 |
| NCT01095133 |
Do Acid Sensing Ion Channels Contribute to Heartburn? |
https://ClinicalTrials.gov/show/NCT01095133 |
Completed |
University of North Carolina, Chapel Hill |
2011-09-30 |
| NCT01079884 |
Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance |
https://ClinicalTrials.gov/show/NCT01079884 |
Completed |
Digestive & Liver Disease Specialists |
2011-03-31 |
| NCT01065649 |
Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) Patients |
https://ClinicalTrials.gov/show/NCT01065649 |
Completed |
Universidade de Passo Fundo |
2010-06-30 |
| NCT01059383 |
Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms |
https://ClinicalTrials.gov/show/NCT01059383 |
Completed |
Vecta Ltd. |
2011-06-30 |
| NCT01058564 |
A Prospective Evaluation of the Torax Medical Inc. Magnetic Esophageal Sphincter |
https://ClinicalTrials.gov/show/NCT01058564 |
Completed |
Torax Medical Incorporated |
2011-10-31 |
| NCT01058070 |
An Observational Clinical Feasibility Study of the Magnetic Esophageal Sphincter |
https://ClinicalTrials.gov/show/NCT01058070 |
Completed |
Torax Medical Incorporated |
2009-07-31 |
| NCT01057992 |
A Prospective Evaluation of the Torax Medical Inc. Magnetic Esophageal Sphincter |
https://ClinicalTrials.gov/show/NCT01057992 |
Completed |
Torax Medical Incorporated |
2009-10-31 |
| NCT01053585 |
Structure and Function of the Gastro-esophageal Junction |
https://ClinicalTrials.gov/show/NCT01053585 |
Completed |
University of Zurich |
2011-05-31 |
| NCT01050465 |
MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use |
https://ClinicalTrials.gov/show/NCT01050465 |
Completed |
University of Missouri-Columbia |
2010-10-31 |
| NCT01047800 |
Functional Gastrointestinal Disorder Screening Program - A Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT01047800 |
Completed |
Chinese University of Hong Kong |
2015-05-31 |
| NCT01047085 |
Does Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique |
https://ClinicalTrials.gov/show/NCT01047085 |
Completed |
Istanbul University |
2009-05-31 |
| NCT01045096 |
Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01045096 |
Completed |
Takeda |
2011-02-28 |
| NCT01043185 |
A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience |
https://ClinicalTrials.gov/show/NCT01043185 |
Completed |
AstraZeneca |
2010-05-31 |
| NCT01039558 |
The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01039558 |
Completed |
Seoul National University Hospital |
2011-03-31 |
| NCT01027975 |
Comparison of Laparoscopic Nissen Versus Thal Fundoplication in Children |
https://ClinicalTrials.gov/show/NCT01027975 |
Completed |
Oxford University Hospitals NHS Trust |
NA |
| NCT01026103 |
Tri Staple Technology Stapler Used in Gastric Bypass |
https://ClinicalTrials.gov/show/NCT01026103 |
Completed |
Medtronic - MITG |
2011-03-31 |
| NCT01009658 |
MSG and Gastrointestinal Motility |
https://ClinicalTrials.gov/show/NCT01009658 |
Completed |
Gunma University |
2015-03-31 |
| NCT01008696 |
An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT01008696 |
Completed |
Janssen Korea, Ltd., Korea |
2008-08-31 |
| NCT01005251 |
Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI |
https://ClinicalTrials.gov/show/NCT01005251 |
Completed |
AstraZeneca |
2010-07-31 |
| NCT00998244 |
Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00998244 |
Completed |
University of North Carolina, Chapel Hill |
2011-12-31 |
| NCT00992589 |
Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00992589 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2011-11-30 |
| NCT00978016 |
A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00978016 |
Completed |
Indivior Inc. |
2010-12-31 |
| NCT00926276 |
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia |
https://ClinicalTrials.gov/show/NCT00926276 |
Completed |
The University of Texas Health Science Center, Houston |
2013-05-31 |
| NCT00911534 |
Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD) |
https://ClinicalTrials.gov/show/NCT00911534 |
Completed |
Eisai Inc. |
2009-07-31 |
| NCT00872755 |
Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00872755 |
Completed |
G. Hatzikosta General Hospital |
2008-04-30 |
| NCT00868296 |
Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00868296 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2008-03-31 |
| NCT00864396 |
Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux |
https://ClinicalTrials.gov/show/NCT00864396 |
Completed |
University of California, Davis |
2008-05-31 |
| NCT00858858 |
Clinical Studies on Bile Acids in Barrett’s Esophagus |
https://ClinicalTrials.gov/show/NCT00858858 |
Completed |
VA Office of Research and Development |
2013-03-31 |
| NCT00855361 |
A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00855361 |
Completed |
Janssen Research & Development, LLC |
2011-12-31 |
| NCT00852098 |
Laparoscopic Nissen Fundoplication Comparing Division Versus Non-Division of Short Gastric Vessels |
https://ClinicalTrials.gov/show/NCT00852098 |
Completed |
Federal University of São Paulo |
2000-01-31 |
| NCT00847808 |
Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy |
https://ClinicalTrials.gov/show/NCT00847808 |
Completed |
Takeda |
2010-04-30 |
| NCT00847210 |
Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00847210 |
Completed |
Takeda |
2009-09-30 |
| NCT00839306 |
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00839306 |
Completed |
Eisai Inc. |
2009-08-31 |
| NCT00838526 |
Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00838526 |
Completed |
Eisai Inc. |
2009-07-31 |
| NCT04433507 |
Antireflux Efficacy of Hiatal Hernia Repairs in Sleeve Gastrectomy Patients |
https://ClinicalTrials.gov/show/NCT04433507 |
Recruiting |
Hopital du Sacre-Coeur de Montreal |
2021-09-01 |
| NCT00838396 |
A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00838396 |
Completed |
Indivior Inc. |
2006-08-31 |
| NCT00815334 |
Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder Compliance |
https://ClinicalTrials.gov/show/NCT00815334 |
Completed |
Samsung Medical Center |
2008-12-31 |
| NCT00810485 |
ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD) |
https://ClinicalTrials.gov/show/NCT00810485 |
Completed |
Addex Pharma S.A. |
2009-12-31 |
| NCT03561090 |
A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors |
https://ClinicalTrials.gov/show/NCT03561090 |
Recruiting |
Ironwood Pharmaceuticals, Inc. |
2021-06-30 |
| NCT02954848 |
Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD) |
https://ClinicalTrials.gov/show/NCT02954848 |
Completed |
Takeda |
2018-02-25 |
| NCT02710994 |
Pharmacodynamics and Safety of CDFR0209 |
https://ClinicalTrials.gov/show/NCT02710994 |
Completed |
Ajou University School of Medicine |
2014-08-31 |
| NCT02579460 |
Reflux-Induced Oxidative Stress in Barrett’s Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition |
https://ClinicalTrials.gov/show/NCT02579460 |
Enrolling by invitation |
Dallas VA Medical Center |
2021-10-31 |
| NCT01570842 |
Anthropometry in Gastroesophageal Reflux Disease and Esophageal Injury |
https://ClinicalTrials.gov/show/NCT01570842 |
Completed |
Mayo Clinic |
2012-11-30 |
| NCT04252144 |
Study of Dietary Patterns and Food Diversity in Russian GERD Patients |
https://ClinicalTrials.gov/show/NCT04252144 |
Recruiting |
Russian Academy of Medical Sciences |
2022-09-30 |
| NCT00787891 |
A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients |
https://ClinicalTrials.gov/show/NCT00787891 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2011-01-31 |
| NCT00786695 |
Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP |
https://ClinicalTrials.gov/show/NCT00786695 |
Completed |
National University Hospital, Singapore |
2009-12-31 |
| NCT00776997 |
LINX Reflux Management System Clinical Study Protocol |
https://ClinicalTrials.gov/show/NCT00776997 |
Completed |
Torax Medical Incorporated |
2010-12-31 |
| NCT00770913 |
Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT00770913 |
Completed |
Eisai Inc. |
2009-11-30 |
| NCT00747695 |
A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive |
https://ClinicalTrials.gov/show/NCT00747695 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00747526 |
A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive |
https://ClinicalTrials.gov/show/NCT00747526 |
Completed |
Janssen Research & Development, LLC |
2012-02-29 |
| NCT00744419 |
Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and Infants |
https://ClinicalTrials.gov/show/NCT00744419 |
Completed |
University of Louisville |
2012-04-30 |
| NCT00734747 |
Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00734747 |
Completed |
Medigus Ltd |
2011-05-31 |
| NCT00734097 |
A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI) |
https://ClinicalTrials.gov/show/NCT00734097 |
Completed |
AstraZeneca |
2008-10-31 |
| NCT00729339 |
Role of Mosapride in Patients With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00729339 |
Completed |
Lotung Poh-Ai Hospital |
2009-04-30 |
| NCT00728481 |
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00728481 |
Completed |
Mayo Clinic |
2010-12-31 |
| NCT00703534 |
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms |
https://ClinicalTrials.gov/show/NCT00703534 |
Completed |
AstraZeneca |
2009-01-31 |
| NCT00688402 |
Study to Compare Different Formulations of AZD3355 |
https://ClinicalTrials.gov/show/NCT00688402 |
Completed |
AstraZeneca |
2008-06-30 |
| NCT00687245 |
Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00687245 |
Completed |
AstraZeneca |
2008-05-31 |
| NCT00684190 |
Drug Interaction Study Between AZD3355 and Nexium |
https://ClinicalTrials.gov/show/NCT00684190 |
Completed |
AstraZeneca |
2008-06-30 |
| NCT00674245 |
Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD. |
https://ClinicalTrials.gov/show/NCT00674245 |
Completed |
Southern Arizona VA Health Care System |
2010-07-31 |
| NCT00660660 |
Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US |
https://ClinicalTrials.gov/show/NCT00660660 |
Completed |
AstraZeneca |
2008-07-31 |
| NCT00658775 |
Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00658775 |
Completed |
Eisai Inc. |
2009-09-30 |
| NCT00658632 |
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00658632 |
Completed |
Eisai Inc. |
2009-04-30 |
| NCT00658528 |
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00658528 |
Completed |
Eisai Inc. |
2009-09-30 |
| NCT00641264 |
Quality of Life Validation in Laryngitis |
https://ClinicalTrials.gov/show/NCT00641264 |
Completed |
AstraZeneca |
2003-06-30 |
| NCT00637845 |
Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00637845 |
Completed |
AstraZeneca |
2003-02-28 |
| NCT00635414 |
Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously |
https://ClinicalTrials.gov/show/NCT00635414 |
Completed |
AstraZeneca |
2002-10-31 |
| NCT00634608 |
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow |
https://ClinicalTrials.gov/show/NCT00634608 |
Completed |
University of Missouri-Columbia |
2009-03-31 |
| NCT00634114 |
Reflux Esophagitis Phase III Study (Maintenance Treatment) |
https://ClinicalTrials.gov/show/NCT00634114 |
Completed |
AstraZeneca |
NA |
| NCT00633932 |
Reflux Esophagitis Phase III Study (Initial Treatment) |
https://ClinicalTrials.gov/show/NCT00633932 |
Completed |
AstraZeneca |
NA |
| NCT00629564 |
An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00629564 |
Completed |
AstraZeneca |
2002-10-31 |
| NCT00628342 |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00628342 |
Completed |
AstraZeneca |
2003-08-31 |
| NCT00627016 |
A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn |
https://ClinicalTrials.gov/show/NCT00627016 |
Completed |
Takeda |
2009-03-31 |
| NCT00626535 |
A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD) |
https://ClinicalTrials.gov/show/NCT00626535 |
Completed |
AstraZeneca |
2004-02-29 |
| NCT00626262 |
Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv |
https://ClinicalTrials.gov/show/NCT00626262 |
Completed |
AstraZeneca |
2002-10-31 |
| NCT00625495 |
Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00625495 |
Completed |
AstraZeneca |
2002-11-30 |
| NCT00618150 |
Patient Education in Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00618150 |
Completed |
Norwegian University of Science and Technology |
1999-12-31 |
| NCT00587522 |
Study of the NDO Endoscopic Plication System For the Treatment of Symptomatic Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00587522 |
Completed |
NDO Surgical, Inc. |
2003-05-31 |
| NCT00576498 |
Novel Imaging Techniques in Barrett’s Esophagus |
https://ClinicalTrials.gov/show/NCT00576498 |
Completed |
Midwest Biomedical Research Foundation |
2009-05-31 |
| NCT00574925 |
Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients |
https://ClinicalTrials.gov/show/NCT00574925 |
Completed |
University of Zurich |
NA |
| NCT00557401 |
An Efficacy and Safety Study of XP19986 in Subjects With Symptomatic GERD |
https://ClinicalTrials.gov/show/NCT00557401 |
Completed |
Indivior Inc. |
2008-09-30 |
| NCT00553449 |
Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms. |
https://ClinicalTrials.gov/show/NCT00553449 |
Completed |
Janssen-Ortho Inc., Canada |
NA |
| NCT00551473 |
Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg. |
https://ClinicalTrials.gov/show/NCT00551473 |
Completed |
GlaxoSmithKline |
NA |
| NCT00539240 |
Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI |
https://ClinicalTrials.gov/show/NCT00539240 |
Completed |
VA Office of Research and Development |
2010-04-30 |
| NCT00521703 |
Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children |
https://ClinicalTrials.gov/show/NCT00521703 |
Completed |
Hospital Infantil Cândido Fontoura |
NA |
| NCT00519441 |
Do Patients Who Have Had Surgery for Achalasia Suffer From Reflux |
https://ClinicalTrials.gov/show/NCT00519441 |
Completed |
University of South Florida |
2009-06-30 |
| NCT00517114 |
Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients |
https://ClinicalTrials.gov/show/NCT00517114 |
Completed |
Hospital Authority, Hong Kong |
NA |
| NCT00509392 |
ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study. |
https://ClinicalTrials.gov/show/NCT00509392 |
Completed |
Medtronic Endovascular |
2008-01-31 |
| NCT00492622 |
Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis |
https://ClinicalTrials.gov/show/NCT00492622 |
Completed |
University of Louisville |
2008-12-31 |
| NCT00476398 |
Evaluation of Patients With Non-cardiac Chest Pain |
https://ClinicalTrials.gov/show/NCT00476398 |
Completed |
Brigham and Women’s Hospital |
2009-06-30 |
| NCT00472550 |
Esomeprazole and Gastric Emptying of Beer |
https://ClinicalTrials.gov/show/NCT00472550 |
Completed |
Heidelberg University |
NA |
| NCT00468559 |
Phase 3/Safety & Efficacy of Esomeprazole in Infants |
https://ClinicalTrials.gov/show/NCT00468559 |
Completed |
AstraZeneca |
2008-06-30 |
| NCT00464308 |
A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg |
https://ClinicalTrials.gov/show/NCT00464308 |
Completed |
Janssen-Cilag Pty Ltd |
2008-05-31 |
| NCT00444275 |
Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients |
https://ClinicalTrials.gov/show/NCT00444275 |
Completed |
AstraZeneca |
2008-10-31 |
| NCT00444145 |
Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment? |
https://ClinicalTrials.gov/show/NCT00444145 |
Completed |
Vanderbilt University Medical Center |
2009-03-31 |
| NCT00427635 |
Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients |
https://ClinicalTrials.gov/show/NCT00427635 |
Completed |
AstraZeneca |
NA |
| NCT00414856 |
Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux |
https://ClinicalTrials.gov/show/NCT00414856 |
Completed |
Novartis |
NA |
| NCT00410592 |
Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD |
https://ClinicalTrials.gov/show/NCT00410592 |
Completed |
AstraZeneca |
NA |
| NCT00405704 |
Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) |
https://ClinicalTrials.gov/show/NCT00405704 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2013-06-30 |
| NCT00405119 |
A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine. |
https://ClinicalTrials.gov/show/NCT00405119 |
Completed |
GlaxoSmithKline |
2007-03-31 |
| NCT00394472 |
Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients |
https://ClinicalTrials.gov/show/NCT00394472 |
Completed |
AstraZeneca |
2007-06-30 |
| NCT00392002 |
Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response |
https://ClinicalTrials.gov/show/NCT00392002 |
Completed |
AstraZeneca |
NA |
| NCT00388453 |
Efficacy of Dx-pH Probe in Diagnosing Extra-esophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00388453 |
Completed |
Vanderbilt University Medical Center |
2012-09-30 |
| NCT00820079 |
ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD) |
https://ClinicalTrials.gov/show/NCT00820079 |
Completed |
Addex Pharma S.A. |
2009-10-31 |
| NCT00384592 |
PPI Sequencing Study |
https://ClinicalTrials.gov/show/NCT00384592 |
Completed |
AstraZeneca |
2007-05-31 |
| NCT00382850 |
Clinical Trial Comparing Open and Laparoscopic Nissen Fundoplication in Children |
https://ClinicalTrials.gov/show/NCT00382850 |
Completed |
Johns Hopkins University |
2010-11-30 |
| NCT00378898 |
Feasibility of Placing Bravo PH Capsule in Proximal Esophagus |
https://ClinicalTrials.gov/show/NCT00378898 |
Completed |
Vanderbilt University Medical Center |
2009-03-31 |
| NCT00373997 |
Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux |
https://ClinicalTrials.gov/show/NCT00373997 |
Completed |
Vanderbilt University |
2009-03-31 |
| NCT00373334 |
Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00373334 |
Completed |
Braintree Laboratories |
2008-02-29 |
| NCT00367614 |
Study Evaluating Pantoprazole in Adolescents With GERD |
https://ClinicalTrials.gov/show/NCT00367614 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00367159 |
Evaluation of the Efficiency of Autologous Adipocytes Graft in Endoscopic Treatment in Vesico-Renal Reflux in Children |
https://ClinicalTrials.gov/show/NCT00367159 |
Recruiting |
University Hospital, Strasbourg, France |
2020-08-31 |
| NCT00365300 |
Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00365300 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-11-30 |
| NCT00362609 |
Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD |
https://ClinicalTrials.gov/show/NCT00362609 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-12-31 |
| NCT00354757 |
CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing |
https://ClinicalTrials.gov/show/NCT00354757 |
Completed |
National Taiwan University Hospital |
2008-06-30 |
| NCT00346905 |
Endoscopic Implantation of Enteryx for the Treatment of GERD |
https://ClinicalTrials.gov/show/NCT00346905 |
Completed |
Beth Israel Deaconess Medical Center |
2008-02-29 |
| NCT00343161 |
Symptom Adapted Therapy in GERD Patients |
https://ClinicalTrials.gov/show/NCT00343161 |
Completed |
AstraZeneca |
2007-08-31 |
| NCT00336219 |
Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343) |
https://ClinicalTrials.gov/show/NCT00336219 |
Completed |
Takeda |
2006-11-30 |
| NCT00326027 |
Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004) |
https://ClinicalTrials.gov/show/NCT00326027 |
Completed |
Nycomed |
2007-07-31 |
| NCT00325676 |
Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342) |
https://ClinicalTrials.gov/show/NCT00325676 |
Completed |
Takeda |
NA |
| NCT00324974 |
The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux |
https://ClinicalTrials.gov/show/NCT00324974 |
Completed |
Takeda |
2007-05-31 |
| NCT00324532 |
to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERD |
https://ClinicalTrials.gov/show/NCT00324532 |
Completed |
BioBalance Corporation |
NA |
| NCT00321984 |
Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00321984 |
Completed |
Takeda |
2006-12-31 |
| NCT00312806 |
Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341) |
https://ClinicalTrials.gov/show/NCT00312806 |
Completed |
Takeda |
2007-03-31 |
| NCT00307944 |
Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea |
https://ClinicalTrials.gov/show/NCT00307944 |
Completed |
University of Cincinnati |
NA |
| NCT00304421 |
Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD |
https://ClinicalTrials.gov/show/NCT00304421 |
Completed |
VA Greater Los Angeles Healthcare System |
NA |
| NCT00300755 |
Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00300755 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2008-04-30 |
| NCT00295685 |
Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD |
https://ClinicalTrials.gov/show/NCT00295685 |
Completed |
Digestive & Liver Disease Specialists |
NA |
| NCT00291746 |
Validation of RDQ Questionnaire |
https://ClinicalTrials.gov/show/NCT00291746 |
Completed |
AstraZeneca |
NA |
| NCT00287612 |
Necessity of Esophageal Dissection During Laparoscopic Fundoplication |
https://ClinicalTrials.gov/show/NCT00287612 |
Completed |
Children’s Mercy Hospital Kansas City |
2009-08-31 |
| NCT00287391 |
Sleep Disorders and Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00287391 |
Completed |
University of North Carolina, Chapel Hill |
NA |
| NCT00284908 |
Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00284908 |
Completed |
STEBA France |
2006-11-30 |
| NCT00272701 |
Esomeprazole in PPI Failures - IMPROVE |
https://ClinicalTrials.gov/show/NCT00272701 |
Completed |
AstraZeneca |
NA |
| NCT00261339 |
Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506) |
https://ClinicalTrials.gov/show/NCT00261339 |
Completed |
Takeda |
NA |
| NCT00261300 |
Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708) |
https://ClinicalTrials.gov/show/NCT00261300 |
Completed |
Takeda |
2007-09-30 |
| NCT00259077 |
Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population |
https://ClinicalTrials.gov/show/NCT00259077 |
Completed |
AstraZeneca |
2004-07-31 |
| NCT00259051 |
A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population |
https://ClinicalTrials.gov/show/NCT00259051 |
Completed |
AstraZeneca |
2004-08-31 |
| NCT00259012 |
Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD |
https://ClinicalTrials.gov/show/NCT00259012 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2008-03-31 |
| NCT00255190 |
Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn |
https://ClinicalTrials.gov/show/NCT00255190 |
Completed |
Takeda |
2008-06-30 |
| NCT00251966 |
ASTERIX: Low Dose ASA and Nexium |
https://ClinicalTrials.gov/show/NCT00251966 |
Completed |
AstraZeneca |
NA |
| NCT00251927 |
Esomeprazole (NEXIUM) vs. Surgery |
https://ClinicalTrials.gov/show/NCT00251927 |
Completed |
AstraZeneca |
2009-04-30 |
| NCT00251901 |
Chest Pain Pilot Study |
https://ClinicalTrials.gov/show/NCT00251901 |
Completed |
AstraZeneca |
2005-07-31 |
| NCT00251758 |
Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn |
https://ClinicalTrials.gov/show/NCT00251758 |
Completed |
Takeda |
2006-05-31 |
| NCT00251745 |
Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn |
https://ClinicalTrials.gov/show/NCT00251745 |
Completed |
Takeda |
2006-05-31 |
| NCT00251732 |
Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI) |
https://ClinicalTrials.gov/show/NCT00251732 |
Completed |
Southern Arizona VA Health Care System |
2010-05-31 |
| NCT00246909 |
Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340) |
https://ClinicalTrials.gov/show/NCT00246909 |
Completed |
Takeda |
2006-11-30 |
| NCT00243724 |
HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease |
https://ClinicalTrials.gov/show/NCT00243724 |
Completed |
AstraZeneca |
2007-06-30 |
| NCT00242736 |
An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00242736 |
Completed |
AstraZeneca |
NA |
| NCT00241501 |
Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients |
https://ClinicalTrials.gov/show/NCT00241501 |
Completed |
AstraZeneca |
NA |
| NCT00237367 |
A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn |
https://ClinicalTrials.gov/show/NCT00237367 |
Completed |
PriCara, Unit of Ortho-McNeil, Inc. |
NA |
| NCT00236392 |
A Study of Efficacy and Safety of “On-demand” Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD) |
https://ClinicalTrials.gov/show/NCT00236392 |
Completed |
Janssen Pharmaceutica N.V., Belgium |
NA |
| NCT00235677 |
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study |
https://ClinicalTrials.gov/show/NCT00235677 |
Completed |
UMC Utrecht |
NA |
| NCT00234117 |
Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression |
https://ClinicalTrials.gov/show/NCT00234117 |
Completed |
Ponce Gastroenterology Research |
NA |
| NCT00231543 |
Laparoscopy in Children: Does it Decrease the Metabolic, Endocrine and Inflammatory Stress Response to Surgery |
https://ClinicalTrials.gov/show/NCT00231543 |
Completed |
Institute of Child Health |
NA |
| NCT00229424 |
Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine - |
https://ClinicalTrials.gov/show/NCT00229424 |
Completed |
Taiho Pharmaceutical Co., Ltd. |
2006-10-31 |
| NCT00228527 |
Esomeprazole for Treatment of GERD in Pediatric Patients |
https://ClinicalTrials.gov/show/NCT00228527 |
Completed |
AstraZeneca |
NA |
| NCT00226044 |
Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants. |
https://ClinicalTrials.gov/show/NCT00226044 |
Completed |
Rijnstate Hospital |
2016-09-30 |
| NCT00222170 |
Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00222170 |
Completed |
University of Kansas Medical Center |
NA |
| NCT00220818 |
A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease. |
https://ClinicalTrials.gov/show/NCT00220818 |
Completed |
Takeda |
2005-07-31 |
| NCT00217347 |
Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy |
https://ClinicalTrials.gov/show/NCT00217347 |
Completed |
Nantes University Hospital |
NA |
| NCT00216489 |
A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00216489 |
Completed |
Janssen Cilag Pharmaceutica S.A.C.I., Greece |
NA |
| NCT00215787 |
Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00215787 |
Completed |
Head and Neck Surgery Associates |
2008-09-30 |
| NCT00214552 |
Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. |
https://ClinicalTrials.gov/show/NCT00214552 |
Completed |
Associated Scientists to Help Minimize Allergies |
2005-03-31 |
| NCT00206180 |
NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00206180 |
Completed |
AstraZeneca |
NA |
| NCT00204698 |
Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment |
https://ClinicalTrials.gov/show/NCT00204698 |
Completed |
University of Utah |
2006-05-31 |
| NCT00200642 |
Evaluation of the Efficiency of Radiofrequency in the Treatment of Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00200642 |
Completed |
Nantes University Hospital |
NA |
| NCT00195208 |
Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00195208 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-11-30 |
| NCT00194376 |
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea |
https://ClinicalTrials.gov/show/NCT00194376 |
Completed |
University of Pennsylvania |
2006-09-30 |
| NCT00184522 |
On Demand Treatment of Reflux Disease |
https://ClinicalTrials.gov/show/NCT00184522 |
Completed |
Norwegian University of Science and Technology |
2004-11-30 |
| NCT00182260 |
A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERD |
https://ClinicalTrials.gov/show/NCT00182260 |
Completed |
McMaster University |
2010-04-30 |
| NCT00174928 |
A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00174928 |
Completed |
Takeda |
2005-08-31 |
| NCT00171483 |
Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). |
https://ClinicalTrials.gov/show/NCT00171483 |
Completed |
Novartis |
NA |
| NCT00171418 |
Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). |
https://ClinicalTrials.gov/show/NCT00171418 |
Completed |
Novartis |
NA |
| NCT00170001 |
Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy |
https://ClinicalTrials.gov/show/NCT00170001 |
Completed |
Mayo Clinic |
2006-08-31 |
| NCT00165841 |
Maintenance Intermittent Therapy for Symptomatic GERD Patients |
https://ClinicalTrials.gov/show/NCT00165841 |
Completed |
Eisai Inc. |
2005-12-31 |
| NCT00165672 |
A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00165672 |
Completed |
Eisai Inc. |
2005-10-31 |
| NCT00165646 |
A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00165646 |
Completed |
Eisai Inc. |
2005-10-31 |
| NCT00164840 |
Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy |
https://ClinicalTrials.gov/show/NCT00164840 |
Completed |
Chinese University of Hong Kong |
2008-11-30 |
| NCT00163306 |
Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339) |
https://ClinicalTrials.gov/show/NCT00163306 |
Completed |
Takeda |
NA |
| NCT00149851 |
A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD) |
https://ClinicalTrials.gov/show/NCT00149851 |
Completed |
Novartis |
2005-06-30 |
| NCT00141960 |
Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00141960 |
Completed |
Astellas Pharma Inc |
NA |
| NCT00141817 |
Study Evaluating Pantoprazole in Children With GERD |
https://ClinicalTrials.gov/show/NCT00141817 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-11-30 |
| NCT00132496 |
Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole |
https://ClinicalTrials.gov/show/NCT00132496 |
Completed |
Eisai Inc. |
2006-05-31 |
| NCT00131248 |
Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants |
https://ClinicalTrials.gov/show/NCT00131248 |
Completed |
The University of Texas Health Science Center, Houston |
2008-03-31 |
| NCT00057174 |
Economic Impact of Guidelines for Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00057174 |
Completed |
VA Office of Research and Development |
NA |
| NCT00818870 |
Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH |
https://ClinicalTrials.gov/show/NCT00818870 |
Completed |
Vecta Ltd. |
2009-06-30 |